Oruka Therapeutics (ORKA) Total Current Liabilities (2010 - 2026)

Oruka Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $16.6 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 41.88% year-over-year to $16.6 million; the TTM figure through Mar 2026 stood at $16.6 million (up 41.88% YoY), while the FY2025 annual figure was $15.4 million, up 17.87% from the prior year.
• Total Current Liabilities was $16.6 million for Q1 2026 at Oruka Therapeutics, up from $15.4 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $21.0 million in Q3 2025 to a low of $637000.0 in Q4 2023.
• Historically, Total Current Liabilities has averaged $7.3 million across 5 years, with a median of $2.7 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities plunged 67.64% in 2022, then soared 1947.57% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $1.1 million in 2022, then sank by 43.73% to $637000.0 in 2023, then jumped by 1947.57% to $13.0 million in 2024, then increased by 17.87% to $15.4 million in 2025, then grew by 8.19% to $16.6 million in 2026.
• The last three Total Current Liabilities figures came in at $16.6 million (Q1 2026), $15.4 million (Q4 2025), and $21.0 million (Q3 2025), per Business Quant data.